1型糖尿病进展与胰岛自身抗体阳性儿童高水平的可溶性PD-1相关
本研究在自身抗体阳性(AAb+)儿童中检测14种可溶性免疫检查点分子(sICM),并与新发1型糖尿病患儿及健康儿童比较;AAb+儿童中进展为1型糖尿病者sICM浓度高于未进展者,且进展者接近发病时sICM水平下降;Cox回归显示高浓度可溶性程序性细胞死亡蛋白1(sPD-1)与1型糖尿病进展相关(HR 1.71;95%CI 1.16, 2.51;p=0.007)。
要点
- AAb+儿童具有区别于健康儿童和新发1型糖尿病患儿的sICM谱。
- AAb+儿童中进展为1型糖尿病者sICM浓度高于未进展者。
- 高浓度sPD-1与1型糖尿病进展相关(HR 1.71;95%CI 1.16, 2.51;p=0.007)。
核心结论
- 本研究揭示1型糖尿病临床前阶段存在失调的sICM谱,并确定sPD-1为与疾病进展相关的病理生理学相关分子,为自身免疫性糖尿病的早期干预提供了潜在靶点。
研究设计与样本
- 纵向研究,检测来自两个队列的AAb+儿童(n=57)、新发1型糖尿病患儿(n=79)和健康儿童(n=44)血清中14种sICM水平。
- AAb+儿童随访后按是否进展为1型糖尿病分为进展组(AAbP)和未进展组(AAbNP),未进展定义为失去胰岛自身免疫且随后数年未发病。
- 在AAbP儿童中,还检测了最接近疾病发病时访视所采集样本的sICM。
主要发现
- AAb+儿童具有区别于健康儿童和新发1型糖尿病患儿的sICM谱。
- AAb+儿童中进展为1型糖尿病者(AAbP)sICM浓度高于未进展者(AAbNP)。
- AAbP儿童接近疾病发病时sICM水平下降。
- Cox回归模型显示,高浓度可溶性程序性细胞死亡蛋白1(sPD-1)与1型糖尿病进展相关(HR 1.71;95%CI 1.16, 2.51;p=0.007)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Type 1 diabetes is an autoimmune disorder that is characterised by destruction of pancreatic beta cells by autoreactive T lymphocytes. Although islet autoantibodies (AAb) are an indicator of disease progression, specific immune biomarkers that can be used as target molecules to halt development of type 1 diabetes have not been discovered. Soluble immune checkpoint molecules (sICM) play a pivotal role in counteracting excessive lymphocyte responses, but their role in type 1 diabetes is unexplored. In this longitudinal study, we measured sICM levels in AAb-positive (AAb+) children to identify molecules related to type 1 diabetes progression. METHODS: We measured the levels of 14 sICM in the sera of AAb+ children (n=57) compared to those with recent-onset type 1 diabetes (n=79) and healthy children (n=44), obtained from two cohorts. AAb+ children were followed up and divided based on their progression to type 1 diabetes (AAbP) or not (AAbNP) (if they lost islet autoimmunity and did not develop disease in subsequent years). sICM were also measured in the sample taken at the visit closest to disease onset in AAbP children. RESULTS: We found that AAb+ children had a distinct sICM profile compared with healthy children and those with recent-onset type 1 diabetes. In addition, AAb+ children who progressed to type 1 diabetes (AAbP) had higher sICM concentrations than non-progressors (AAbNP). Further, sICM levels decreased in AAbP children close to disease onset. Application of Cox regression models highlighted that high concentrations of soluble programmed cell death protein 1 (sPD-1) are associated with type 1 diabetes progression (HR 1.71; 95% CI 1.16, 2.51; p=0.007). CONCLUSIONS/INTERPRETATION: This study reveals an sICM profile that is dysregulated during the preclinical stage of type 1 diabetes, and identifies sPD-1 as a pathophysiologically-relevant molecule that is associated with disease progression, offering a potential target for early interventions in autoimmune diabetes.
引用
- Bruzzaniti S, Piemonte E, Bruzzese D, et al. Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children. Diabetologia. 2024. PMID: 38214712. doi:10.1007/s00125-023-06075-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。